Communication between patients and providers and informed decision making.

Women with ductal carcinoma in situ (DCIS) need to comprehend the meaning of the diagnosis and the potential benefits and harms of treatment options. Full and understandable information is a requirement, not an option. However, with DCIS, as with many areas of medicine, a high level of uncertainty about the disease remains. In this article, we define informed medical decision making, review challenges to its implementation, and provide suggestions on how to improve communication with women about the diagnosis and treatment of DCIS.

[1]  J. G. Hollands,et al.  The visual communication of risk. , 1999, Journal of the National Cancer Institute. Monographs.

[2]  W. Burke,et al.  Misleading presentation of breast cancer in popular magazines. , 2001, Effective clinical practice : ECP.

[3]  Phyllis Butow,et al.  A systematic review on communicating with patients about evidence. , 2006, Journal of evaluation in clinical practice.

[4]  Steven Woloshin,et al.  The risk of death by age, sex, and smoking status in the United States: putting health risks in context. , 2008, Journal of the National Cancer Institute.

[5]  Aileen Clarke,et al.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process , 2006, BMJ : British Medical Journal.

[6]  Gary R Cutter,et al.  Mammographers’ Perception of Women’s Breast Cancer Risk , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  R. Kane,et al.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. , 2010, Journal of the National Cancer Institute.

[8]  B. Lerner,et al.  The Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth Century America , 2001, Nursing History Review.

[9]  T. Tuttle,et al.  Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  B. Rimer,et al.  Informed decision making: What is its role in cancer screening? , 2004, Cancer.

[11]  N. Bristow.  Battling Breast Cancer , 2002 .

[12]  Russell S. Kirby,et al.  The Dartmouth Atlas of Health Care , 1998 .

[13]  I. Lipkus.  Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future Recommendations , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  Lisa M. Schwartz,et al.  Risk communication in clinical practice: putting cancer in context. , 1999, Journal of the National Cancer Institute. Monographs.

[15]  D. Redelmeier,et al.  A Comparison of Risk Perception and Psychological Morbidity in Women with Ductal Carcinoma in situ and Early Invasive Breast Cancer , 2003, Breast Cancer Research and Treatment.

[16]  Steven Woloshin,et al.  The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography. , 2008, Journal of the National Cancer Institute.

[17]  J Costantino,et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.

[18]  Ronald M Epstein,et al.  Communicating evidence for participatory decision making. , 2004, JAMA.

[19]  J. Van den Bulck,et al.  Television news exposure is related to fear of breast cancer. , 2009, Preventive medicine.

[20]  P. Gøtzsche,et al.  Informed choice requires information about both benefits and harms , 2009, Journal of Medical Ethics.

[21]  C. McHorney,et al.  Frequency or Probability? A Qualitative Study of Risk Communication Formats Used in Health Care , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  H. Gilbert Welch,et al.  Should I Be Tested for Cancer?: Maybe Not and Here's Why , 2004 .

[23]  A. Vingerhoets,et al.  A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. , 2007, European journal of cancer.

[24]  R F Nease,et al.  Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. , 1995, Journal of the National Cancer Institute.

[25]  J. Goodwin,et al.  Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. , 1998, JAMA.

[26]  J Dundon,et al.  Interventions to improve risk communication in clinical genetics: systematic review. , 2008, Patient education and counseling.

[27]  B. Rimer,et al.  General Performance on a Numeracy Scale among Highly Educated Samples , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  Geoff Delaney M.B.B.S.,et al.  Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis , 1999 .

[29]  K. Malone,et al.  Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988‐2001 , 2006, Cancer.

[30]  P. Slovic,et al.  Numeracy skill and the communication, comprehension, and use of risk-benefit information. , 2007, Health affairs.

[31]  Jessica S. Ancker,et al.  The Practice of Informatics: Design Features of Graphs in Health Risk Communication: A Systematic Review , 2006, J. Am. Medical Informatics Assoc..

[32]  Gerd Gigerenzer,et al.  Calculated Risks: How to Know When Numbers Deceive You , 2002 .

[33]  Stephen M Hahn,et al.  NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). , 2009, NIH consensus and state-of-the-science statements.

[34]  Karla Kerlikowske,et al.  Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. , 2010, Journal of the National Cancer Institute.

[35]  Amiram Gafni,et al.  Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. , 2004, JAMA.

[36]  E. Winer,et al.  Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. , 2008, Journal of the National Cancer Institute.

[37]  P. Ubel,et al.  Cure Me Even If It Kills Me: Preferences for Invasive Cancer Treatment , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  Lisa M. Schwartz,et al.  The Role of Numeracy in Understanding the Benefit of Screening Mammography , 1997, Annals of Internal Medicine.

[39]  B. Geller,et al.  Communicating with women about mammography , 2007, Journal of Cancer Education.

[40]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[41]  E. Winer,et al.  Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. , 2001, Journal of women's health & gender-based medicine.

[42]  Jean-Luc Bulliard,et al.  Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. , 2006, Patient education and counseling.

[43]  Eduardo Bruera,et al.  Treatment decisions for breast carcinoma , 2002, Cancer.